Form 4: Incyte Corp Executive Christiana Stamoulis Reports Stock Transaction

Christiana Stamoulis, EVP & Chief Financial Officer of Incyte Corp, reported the withholding of 3,672 shares of common stock to cover tax obligations.

Summary

• Christiana Stamoulis, the EVP & Chief Financial Officer of Incyte Corp, filed a Form 4 indicating a transaction involving the company's stock.
• On January 15, 2025, 3,672 shares of common stock were withheld to cover tax obligations related to the settlement of previously reported RSUs and earned performance shares.
• Following this transaction, Stamoulis beneficially owns 91,525 shares of Incyte Corp common stock, which includes 46,753 unvested shares from previously reported RSUs and earned performance shares.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing related to executive stock transactions, which is neither positive nor negative. The sentiment is neutral to slightly positive as it reflects standard compensation practices.

Industry Context

This is a routine filing related to executive compensation and stock ownership, common in publicly traded companies.

Comparison to Industry Standards

• Form 4 filings are standard practice for corporate insiders in publicly traded companies, such as Incyte Corp, and are required by the SEC.
• The transaction is typical of tax withholding related to the vesting of stock-based compensation, a common practice across the industry.
• Similar filings can be seen from executives at comparable companies such as Gilead Sciences, Regeneron Pharmaceuticals, and Vertex Pharmaceuticals.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it is a standard tax withholding event.
• The transaction does not directly impact employees, customers, suppliers, or creditors.

Key Dates

Keywords

Form 4, Incyte Corp, Stock Transaction, Beneficial Ownership, Christiana Stamoulis, RSUs, Tax Withholding, Executive Compensation